Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Substance Withdrawal Syndrome”

163 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 163 results

Testing effectiveness (Phase 2)UnknownNCT02249026
What this trial is testing

Sublingual Buprenorphine Treatment for Neonatal Abstinence Syndrome - Pilot Study

Who this might be right for
Drug; Withdrawal Symptoms, NeonatalWithdrawalFetus and Newborn Affected by Other Maternal Medication
Gauda, Estelle B., M.D. 40
Post-approval studies (Phase 4)Study completedNCT01675648
What this trial is testing

Lofexidine for Inpatient Opiate Detox in Singapore

Who this might be right for
Opiate Dependent Patients Who Are Undergoing Inpatient Detoxification in Singapore
Institute of Mental Health, Singapore 112
Not applicableStudy completedNCT04731935
What this trial is testing

Novel Earpiece for Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal

Who this might be right for
Opioid-use DisorderOpioid Withdrawal
Spark Biomedical, Inc. 6
Not applicableStudy completedNCT03973801
What this trial is testing

Feasibility of Auricular Acupressure as an Adjunct Treatment for Neonatal Abstinence Syndrome (NAS)

Who this might be right for
Neonatal Abstinence SyndromeWithdrawal
Vanderbilt University Medical Center 12
Testing effectiveness (Phase 2)UnknownNCT04850664
What this trial is testing

Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder

Who this might be right for
Opioid Use Disorder, ModerateOpioid Use Disorder, SevereWithdrawal Symptoms+2 more
Evon Medics LLC 190
Not applicableStudy completedNCT03565016
What this trial is testing

Consequences of At-risk Alcohol Consumption in ICU Patients

Who this might be right for
Alcohol AbuseAlcoholism
Nantes University Hospital 150
Post-approval studies (Phase 4)Ended earlyNCT01362205
What this trial is testing

Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD)

Who this might be right for
Alcohol Withdrawal DeliriumAlcohol Withdrawal Associated Autonomic HyperactivityAlcohol Withdrawal Hallucinosis+1 more
Denver Health and Hospital Authority 49
Large-scale testing (Phase 3)Ended earlyNCT02052440
What this trial is testing

Preventing Alcohol Withdrawal Syndrome With Oral Baclofen

Who this might be right for
Alcohol Withdrawal Syndrome
Denver Health and Hospital Authority 102
Testing effectiveness (Phase 2)Ended earlyNCT03645603
What this trial is testing

Efficacy and Safety of Dexmedetomidine During Weaning From Analgesia and Sedation in PICU (TIP-15-01)

Who this might be right for
Withdrawal Syndrome
IRCCS Azienda Ospedaliero-Universitaria di Bologna 45
Post-approval studies (Phase 4)Ended earlyNCT01100437
What this trial is testing

Safety Study to Assess Opiate Withdrawal Signs and Symptoms in Opioid Dependent Patients

Who this might be right for
Chronic Pain
Pfizer 14
Not applicableStudy completedNCT02952846
What this trial is testing

Tapering of Analgosedation and Occurrence of Withdrawal Syndrome in Paediatric Intensive Care Treatment

Who this might be right for
Drug Withdrawal SymptomsCritical CareChild
Oslo University Hospital 80
Not applicableStudy completedNCT05697783
What this trial is testing

Methadone vs. Transdermal Fentanyl for Opioid Withdrawal Syndrome

Who this might be right for
Delirium in the Intensive Care Unit
Meir Medical Center 100
Large-scale testing (Phase 3)Study completedNCT03911739
What this trial is testing

Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study

Who this might be right for
Opioid-Related DisordersDrug AddictionPregnancy Related+5 more
T. John Winhusen, PhD 71
Early research (Phase 1)Study completedNCT01650649
What this trial is testing

Main Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients

Who this might be right for
Opioid DependenceMethadone Withdrawal Syndrome
USWM, LLC (dba US WorldMeds) 27
Not applicableStudy completedNCT04429568
What this trial is testing

THC Crossover Study

Who this might be right for
THCCannabisCannabis Smoking+6 more
University of California, San Francisco 14
Large-scale testing (Phase 3)Study completedNCT01958476
What this trial is testing

Improving Outcomes in Neonatal Abstinence Syndrome

Who this might be right for
Neonatal Abstinence SyndromeNeonatal Opioid Withdrawal
Tufts Medical Center 117
Not applicableStudy completedNCT06410287
What this trial is testing

Testing an Arts-based Program to Reduce Nurse Stigma Towards Perinatal Substance Use

Who this might be right for
Nurse's RoleStigma, SocialImplicit Bias
University of Michigan 100
Not applicableStudy completedNCT02825459
What this trial is testing

Does Abstinence From E-cigarettes Produce Withdrawal Symptoms?

Who this might be right for
Substance Withdrawal Syndrome
University of Vermont 147
Not applicableStudy completedNCT04834297
What this trial is testing

Use of SVS Device to Improve Outcomes for Neonatal Opioid Withdrawal Syndrome.

Who this might be right for
Neonatal Opioid Withdrawal Syndrome
Tufts Medical Center 120
Early research (Phase 1)Study completedNCT01204723
What this trial is testing

Medications Development for the Treatment of Cannabis Related Disorders

Who this might be right for
Nicotine WithdrawalMarijuana DependenceCannabis Dependence+2 more
University of Virginia 63
Load More Results